🚀 VC round data is live in beta, check it out!
Dr. Sulaiman Al Habib Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr. Sulaiman Al Habib and similar public comparables like Sigma Healthcare, JD Health, IHH Healthcare, Fresenius and more.
Dr. Sulaiman Al Habib Overview
About Dr. Sulaiman Al Habib
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
Founded
1993
HQ
Employees
N/A
Website
Financials (LTM)
EV
$25B
Dr. Sulaiman Al Habib Financials
Dr. Sulaiman Al Habib reported last 12-month revenue of $4B and EBITDA of $931M.
In the same LTM period, Dr. Sulaiman Al Habib generated $1B in gross profit, $931M in EBITDA, and $675M in net income.
Revenue (LTM)
Dr. Sulaiman Al Habib P&L
In the most recent fiscal year, Dr. Sulaiman Al Habib reported revenue of $4B and EBITDA of $942M.
Dr. Sulaiman Al Habib expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 31% | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $931M | XXX | $942M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $675M | XXX | $641M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dr. Sulaiman Al Habib Stock Performance
Dr. Sulaiman Al Habib has current market cap of $24B, and enterprise value of $25B.
Market Cap Evolution
Dr. Sulaiman Al Habib's stock price is $67.41.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25B | $24B | 0.0% | XXX | XXX | XXX | $1.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr. Sulaiman Al Habib Valuation Multiples
Dr. Sulaiman Al Habib trades at 6.7x EV/Revenue multiple, and 27.4x EV/EBITDA.
EV / Revenue (LTM)
Dr. Sulaiman Al Habib Financial Valuation Multiples
As of April 18, 2026, Dr. Sulaiman Al Habib has market cap of $24B and EV of $25B.
Equity research analysts estimate Dr. Sulaiman Al Habib's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr. Sulaiman Al Habib has a P/E ratio of 35.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24B | XXX | $24B | XXX | XXX | XXX |
| EV (current) | $25B | XXX | $25B | XXX | XXX | XXX |
| EV/Revenue | 6.7x | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBITDA | 27.4x | XXX | 27.0x | XXX | XXX | XXX |
| EV/EBIT | 34.6x | XXX | 36.2x | XXX | XXX | XXX |
| EV/Gross Profit | 21.5x | XXX | 22.7x | XXX | XXX | XXX |
| P/E | 35.0x | XXX | 36.8x | XXX | XXX | XXX |
| EV/FCF | 192.1x | XXX | 228.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr. Sulaiman Al Habib Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dr. Sulaiman Al Habib Margins & Growth Rates
Dr. Sulaiman Al Habib's revenue in the last 12 month grew by 15%.
Dr. Sulaiman Al Habib's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr. Sulaiman Al Habib's rule of X is 63% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dr. Sulaiman Al Habib Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 40% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 63% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 5% | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 8% | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dr. Sulaiman Al Habib Public Comps
See public comps and valuation multiples for other Hospitals & Clinics and Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dr. Sulaiman Al Habib | XXX | XXX | XXX | XXX | XXX | XXX |
| Sigma Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| JD Health | XXX | XXX | XXX | XXX | XXX | XXX |
| IHH Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
| Rede D'Or São Luiz | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Sulaiman Al Habib M&A Activity
Dr. Sulaiman Al Habib acquired XXX companies to date.
Last acquisition by Dr. Sulaiman Al Habib was on XXXXXXXX, XXXXX. Dr. Sulaiman Al Habib acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dr. Sulaiman Al Habib
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDr. Sulaiman Al Habib Investment Activity
Dr. Sulaiman Al Habib invested in XXX companies to date.
Dr. Sulaiman Al Habib made its latest investment on XXXXXXXX, XXXXX. Dr. Sulaiman Al Habib invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dr. Sulaiman Al Habib
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr. Sulaiman Al Habib
| When was Dr. Sulaiman Al Habib founded? | Dr. Sulaiman Al Habib was founded in 1993. |
| Where is Dr. Sulaiman Al Habib headquartered? | Dr. Sulaiman Al Habib is headquartered in Saudi Arabia. |
| Who is the CEO of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's CEO is Faisal Abdullah Al Nassar. |
| Is Dr. Sulaiman Al Habib publicly listed? | Yes, Dr. Sulaiman Al Habib is a public company listed on Tadawul. |
| What is the stock symbol of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib trades under 4013 ticker. |
| When did Dr. Sulaiman Al Habib go public? | Dr. Sulaiman Al Habib went public in 2020. |
| Who are competitors of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib main competitors are Sigma Healthcare, JD Health, IHH Healthcare, Fresenius. |
| What is the current market cap of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's current market cap is $24B. |
| What is the current revenue of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months revenue is $4B. |
| What is the current revenue growth of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Dr. Sulaiman Al Habib? | Current revenue multiple of Dr. Sulaiman Al Habib is 6.7x. |
| Is Dr. Sulaiman Al Habib profitable? | Yes, Dr. Sulaiman Al Habib is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months EBITDA is $931M. |
| What is Dr. Sulaiman Al Habib's EBITDA margin? | Dr. Sulaiman Al Habib's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Dr. Sulaiman Al Habib? | Current EBITDA multiple of Dr. Sulaiman Al Habib is 27.4x. |
| What is the current FCF of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months FCF is $133M. |
| What is Dr. Sulaiman Al Habib's FCF margin? | Dr. Sulaiman Al Habib's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Dr. Sulaiman Al Habib? | Current FCF multiple of Dr. Sulaiman Al Habib is 192.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.